First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan

Overview

Journal Sci Rep

Specialty Science

Date 2019 May 16

PMID 31086199

Citations 5

Authors

Sayed Hamid Mousavi

Niloofar Khairkhah

Tina Delsouz Bahri

Ali Anvar

Alireza Azizi Saraji

Bita Behnava

Seyed Moayed Alavian

Ali Namvar

Affiliations

Soon will be listed here.

Abstract

Blood-borne viruses including Hepatitis B and C, HIV, HTLV-1 and parvovirus B19 are still a factor of concern, especially for hemophilia patients. Although the safety of the blood supply continues to improve worldwide, the blood supply system in Afghanistan was damaged by many years of conflict and political instability. To date, there are few studies focused on the prevalence of blood-borne viruses in hemophilia patients. This study is first to investigate the prevalence of five blood-borne viruses in Afghanistan hemophilia patients in four cities including Kabul, Herat, Mazar-i-Sharif and Jalal Abad. A total of 80 hemophilia male patients were screening for the presence of five transfusion-transmitted viruses using ELISA and PCR. Data obtained showed 2.5% seropositivity for HBV, 8.75% seropositivity for HCV, and 91.25% seropositivity for parvovirus B19. None of the patients were positive for HIV and HTLV-1 and the prevalence of HCV was higher in older patients rather than younger patients. This finding, the first to report in Afghanistan, shows a high prevalence of parvovirus B19 in Afghanistan hemophilia patients and implementation of highly sensitive screening is necessary.

Citing Articles

Immigrating and vicinity are not risk factors in the prevalence and transmission rate of human T-lymphotropic virus type 1: A Survey in an endemic region of Iran and Afghan refugees.

Mahdifar M, Akbari-Eidgahi M, Mosavat A, Pourreza A, Akbarin M, Valizadeh N PLOS Glob Public Health. 2023; 3(1):e0001484.

PMID: 36962855 PMC: 10021442. DOI: 10.1371/journal.pgph.0001484.

The Profile of Markers of Bone Turnover, Inflammation and Extracellular Neutrophil Traps on Bone Mass in Haemophilia and the Development of Haemophilic Arthropathy.

Czajkowska S, Rupa-Matysek J, Wojtasinska E, Nijakowski K, Surdacka A, Gil L J Clin Med. 2022; 11(16).

PMID: 36012950 PMC: 9410524. DOI: 10.3390/jcm11164711.

Transfusion of fibrinogen concentrate before dental extractions in patients with afibrinogenemia: a narrative review supported by a case report with a proposed treatment protocol.

Czajkowska S, Rupa-Matysek J, Brzezinska J, Surdacka A, Gil L Blood Transfus. 2022; 21(2):168-175.

PMID: 35969135 PMC: 10072993. DOI: 10.2450/2022.0037-22.

Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran.

Hedayati-Moghaddam M, Esfehani R, El Hajj H, Bazarbachi A Viruses. 2022; 14(4).

PMID: 35458394 PMC: 9029775. DOI: 10.3390/v14040664.

Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review.

Czajkowska S, Rupa-Matysek J, Gil L, Surdacka A Int J Environ Res Public Health. 2020; 17(19).

PMID: 33023050 PMC: 7579117. DOI: 10.3390/ijerph17197245.

References

Marano G, Vaglio S, Pupella S, Facco G, Calizzani G, Candura F . Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015; 13(2):184-96. PMC: 4385066. DOI: 10.2450/2014.0174.14. View

Zimmerman B, Valentino L . Hemophilia: in review. Pediatr Rev. 2013; 34(7):289-94. DOI: 10.1542/pir.34-7-289. View

Gessain A, Cassar O . Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012; 3:388. PMC: 3498738. DOI: 10.3389/fmicb.2012.00388. View

Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M . Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007; 28(10):1516-9. View

Nasir A, Todd C, Stanekzai M, Bautista C, Botros B, Scott P . Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy. 2010; 22(2):145-52. PMC: 7243866. DOI: 10.1016/j.drugpo.2010.10.006. View

Anderson M, Lewis E, Kidd I, Hall S, Cohen B . An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond). 1984; 93(1):85-93. PMC: 2129271. DOI: 10.1017/s0022172400060964. View

Ke L, He M, Li C, Liu Y, Gao L, Yao F . The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion. 2011; 51(9):1909-18. DOI: 10.1111/j.1537-2995.2011.03067.x. View

Hedayati-Moghaddam M, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori H . Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2012; 13(6):424-7. PMC: 3371930. View

Mannucci P . Hemophilia: treatment options in the twenty-first century. J Thromb Haemost. 2003; 1(7):1349-55. DOI: 10.1046/j.1538-7836.2003.00262.x. View

10.

Appourchaux P, Huart J, Burnouf T . Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates. Vox Sang. 1994; 67(2):132-8. DOI: 10.1111/j.1423-0410.1994.tb01647.x. View

11.

Khattak M, Salamat N, Bhatti F, Qureshi T . Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2003; 52(9):398-402. View

12.

Azarpazhooh M, Hasanpour K, Ghanbari M, Rahim Rezaee S, Mashkani B, Hedayati-Moghaddam M . Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012; 28(9):1095-1101. DOI: 10.1089/AID.2011.0248. View

13.

Khan S, Attaullah S . Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile?. Virol J. 2011; 8:216. PMC: 3125356. DOI: 10.1186/1743-422X-8-216. View

14.

Assarehzadegan M, Ghafourian Boroujerdnia M, Zandian K . Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iran Red Crescent Med J. 2012; 14(8):470-4. PMC: 3470840. View

15.

Groeneveld K, van der Noordaa J . Blood products and parvovirus B19. Neth J Med. 2003; 61(5):154-6. View

16.

Mannucci P, Tuddenham E . The hemophilias--from royal genes to gene therapy. N Engl J Med. 2001; 344(23):1773-9. DOI: 10.1056/NEJM200106073442307. View

17.

Todd C, Abed A, Strathdee S, Scott P, Botros B, Safi N . HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2008; 13(9):1327-31. PMC: 2857281. DOI: 10.3201/eid1309.070036. View

18.

Cossart Y, Field A, Cant B, Widdows D . Parvovirus-like particles in human sera. Lancet. 1975; 1(7898):72-3. DOI: 10.1016/s0140-6736(75)91074-0. View

19.

Kishore J, Srivastava M, Choudhary N . Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors. Asian J Transfus Sci. 2010; 4(2):86-90. PMC: 2937302. DOI: 10.4103/0973-6247.67022. View

20.

Rezvan H, Abolghassemi H, Kafiabad S . Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17(6):425-33. DOI: 10.1111/j.1365-3148.2007.00794.x. View